This inventor holds 1 USPTO granted patent. Top assignees: Eotvos Lorand Tudomanyegyetem, Printnet Kereskedelmi És Szolgáltató Kft.. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 6 
1 out of 3 Years Active: 2025
Title: The Innovations of István Lórincz
Introduction
István Lórincz is a notable inventor based in Budapest, Hungary. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that inhibit myosin 2 isoforms. His work has the potential to impact various therapeutic applications.
Latest Patents
Lórincz holds a patent for "Pharmaceutically effective compounds inhibiting selectively the myosin 2 isoforms." This invention relates to compounds of formula (I) or (II), including pharmaceutically acceptable salts, solvates, tautomers, stereoisomers, and various mixtures. The pharmaceutical uses of these compounds are of great interest in the medical community.
Career Highlights
Throughout his career, István Lórincz has worked with several organizations, including Printnet Kereskedelmi és Szolgáltató Kft. and Eötvös Loránd University. His experience in these institutions has contributed to his expertise in pharmaceutical innovations.
Collaborations
Lórincz has collaborated with notable colleagues such as András Málnási-Csizmadia and Máté Gyimesi. These partnerships have likely enriched his research and development efforts.
Conclusion
István Lórincz is a prominent figure in the field of pharmaceutical innovation, with a focus on myosin 2 isoforms. His contributions through patents and collaborations highlight his commitment to advancing medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile